At this stage , I would not think it likely. There has been no further submissions to the docket and we are now well past the point were the FDA could have approved the BLA.
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-974
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
-0.015(1.60%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 95.0¢ | 91.8¢ | $938.9K | 1.012M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 55184 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 11549 | 9 |
View Market Depth
| Last trade - 11.44am 16/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |